|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's Range||19.24 - 20.83|
|52 Week Range||2.06 - 32.43|
|Beta (5Y Monthly)||2.41|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||31.67|
In this article we will take a look at the 10 best augmented reality stocks to buy now. You can skip our detailed analysis of these companies and go directly to the 5 Best Augmented Reality Stocks to Buy Now. There is a growing proliferation of Augmented Reality (AR) across the world and many tech […]
Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that Pixee Medical, a France-based supplier of high-performance computer-assisted surgery solutions, has received 510K clearance from the U.S. Food and Drug Administration (FDA) for its Knee+ total knee replacement surgery solution and placed a follow-on Vuzix M400 Smart Glasses order that will more than double the total amount of systems deployed to date by Pixee Medical to ambulatory surgical centers.
Share prices of Vuzix (NASDAQ: VUZI), a developer of augmented reality devices, skyrocketed nearly 1,500% over the past 12 months as demand for its glasses and headsets surged throughout the pandemic. Is Vuzix still a good investment on the AR market, or is there far too much growth baked into its stock price already? Vuzix went public in 2013, the same year Alphabet's (NASDAQ: GOOG) (NASDAQ: GOOGL) Google unveiled Google Glass.